Jing Zhu is an accomplished pharmaceutical professional with extensive experience in CMC management and drug development. Currently serving as Senior Director and Head of CMC at ά•NÒ©Òµ since January 2022, Jing has previously held significant roles at I-Mab Biopharma as Director and Associate Director in CMC Management, overseeing formulation and analytical development. Prior experience includes a position at Baxter International Inc. as Tech Lead, where Jing directed new pharmaceutical product development initiatives, and a role as Group Leader in formulation development at WuXi AppTec China. Jing's academic background includes a PhD in Pharmacy from the University of Nottingham, along with a Master's in Pharmaceutics and a Bachelor's in Medicine from Tianjin University and Hebei University, respectively.